Sorry, but unless 113 shows it head in egfr, I don't see it. 113 would be a me too in Alk + (although a potentialy better me too). I don't know enough about breakthrough status to opine if 113 would qualify for it w/o filing an unmet need (ie egfr).
This, along with Harv's sales, is a modestly bearish development to the simpleton crowd in the short term as I see it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.